Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
TAIPEI, May 22, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy of TSY-310, a novel bispecific antibody-drug conjugate (ADC), has been selected...
Santec AOC Unveils LCOS-based SLM-310 for 1kW-class Near-infrared Laser Processing
KOMAKI, Japan, May 27, 2025 /PRNewswire/ -- Santec AOC Corporation (hereinafter "Santec AOC"), headquartered in Komaki City, Aichi Prefecture, has announced the development of its latest product, the SLM-310, a liquid crystal on silicon (LCOS)-based...
Verismo Therapeutics Announces Strategic Partnership with IFLI to Support SynKIR™-310 Development in Follicular Lymphoma
Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI). The partnership with IFLI will accelerate the clinical development of SynKIR™-310 in Follicular Lymphoma (FL) by leveraging...